Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma
Frei, E., Visco, C., Xu-Monette, Z. Y., Dirnhofer, S., Dybkaer, K., Orazi, A., Bhagat, G., Hsi, E. D., van Krieken, J. H., Ponzoni, M., Go, R. S., Piris, M. A., Moller, M. B., Young, K. H., Tzankov, AТом:
66
Мова:
english
Журнал:
Journal of Clinical Pathology
DOI:
10.1136/jclinpath-2013-201619
Date:
November, 2013
Файл:
PDF, 2.66 MB
english, 2013